These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23665564)

  • 1. Reinterpreting the action of ATP analogs on K(ATP) channels.
    Ortiz D; Gossack L; Quast U; Bryan J
    J Biol Chem; 2013 Jun; 288(26):18894-902. PubMed ID: 23665564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
    Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
    J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2.
    Ortiz D; Voyvodic P; Gossack L; Quast U; Bryan J
    J Biol Chem; 2012 May; 287(22):17985-95. PubMed ID: 22451668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
    de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
    Yamada M; Kurachi Y
    J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
    Hosy E; Dérand R; Revilloud J; Vivaudou M
    J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
    Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
    J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.
    Okeyo G; Wang W; Wei S; Kirk KL
    J Biol Chem; 2013 Jun; 288(24):17122-33. PubMed ID: 23620589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
    Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
    Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes.
    de Wet H; Proks P; Lafond M; Aittoniemi J; Sansom MS; Flanagan SE; Pearson ER; Hattersley AT; Ashcroft FM
    EMBO Rep; 2008 Jul; 9(7):648-54. PubMed ID: 18497752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in nucleotide-binding domains of sulfonylurea receptor 2 evokes Na-ATP-dependent activation of ATP-sensitive K+ channels: implication for dimerization of nucleotide-binding domains to induce channel opening.
    Yamada M; Ishii M; Hibino H; Kurachi Y
    Mol Pharmacol; 2004 Oct; 66(4):807-16. PubMed ID: 15258252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).
    Babenko AP; Vaxillaire M
    FEBS Lett; 2011 Nov; 585(22):3555-9. PubMed ID: 22020219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K; Komine J; Matsuo M; Seino S; Amachi T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.